6-139373365-CGCCGCT-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_006079.5(CITED2):βc.574_579delβ(p.Ser192_Gly193del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000174 in 1,583,402 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Benign (β ).
Frequency
Genomes: π 0.00026 ( 0 hom., cov: 32)
Exomes π: 0.00017 ( 3 hom. )
Consequence
CITED2
NM_006079.5 inframe_deletion
NM_006079.5 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.53
Genes affected
CITED2 (HGNC:1987): (Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2) The protein encoded by this gene inhibits transactivation of HIF1A-induced genes by competing with binding of hypoxia-inducible factor 1-alpha to p300-CH1. Mutations in this gene are a cause of cardiac septal defects. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 6-139373365-CGCCGCT-C is Benign according to our data. Variant chr6-139373365-CGCCGCT-C is described in ClinVar as [Benign]. Clinvar id is 1684895.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 39 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CITED2 | NM_006079.5 | c.574_579del | p.Ser192_Gly193del | inframe_deletion | 2/2 | ENST00000367651.4 | NP_006070.2 | |
CITED2 | NM_001168388.3 | c.574_579del | p.Ser192_Gly193del | inframe_deletion | 2/2 | NP_001161860.1 | ||
CITED2 | NM_001168389.3 | c.589_594del | p.Ser197_Gly198del | inframe_deletion | 2/2 | NP_001161861.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CITED2 | ENST00000367651.4 | c.574_579del | p.Ser192_Gly193del | inframe_deletion | 2/2 | 1 | NM_006079.5 | ENSP00000356623 | P1 | |
ENST00000650173.1 | n.510-55714_510-55709del | intron_variant, non_coding_transcript_variant | ||||||||
CITED2 | ENST00000536159.2 | c.574_579del | p.Ser192_Gly193del | inframe_deletion | 2/2 | 3 | ENSP00000442831 | P1 | ||
CITED2 | ENST00000537332.2 | c.589_594del | p.Ser197_Gly198del | inframe_deletion | 2/2 | 3 | ENSP00000444198 |
Frequencies
GnomAD3 genomes AF: 0.000257 AC: 39AN: 151578Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
39
AN:
151578
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000586 AC: 127AN: 216568Hom.: 1 AF XY: 0.000480 AC XY: 58AN XY: 120856
GnomAD3 exomes
AF:
AC:
127
AN:
216568
Hom.:
AF XY:
AC XY:
58
AN XY:
120856
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000166 AC: 237AN: 1431714Hom.: 3 AF XY: 0.000149 AC XY: 106AN XY: 712600
GnomAD4 exome
AF:
AC:
237
AN:
1431714
Hom.:
AF XY:
AC XY:
106
AN XY:
712600
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000257 AC: 39AN: 151688Hom.: 0 Cov.: 32 AF XY: 0.000337 AC XY: 25AN XY: 74176
GnomAD4 genome
AF:
AC:
39
AN:
151688
Hom.:
Cov.:
32
AF XY:
AC XY:
25
AN XY:
74176
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
CITED2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at